Long-term Efficacy and Safety of Fecal Microbiota Transplantation in Patients With Ulcerative Colitis

This study aims to perform fecal microbiota transplantation (FMT) and analyze its effects in selected patients aged between 10 and 80 years who have been diagnosed with ulcerative colitis and have been receiving treatment for more than three months at Seoul National University Hospital, Seoul National University Boramae Medical Center, and Seoul National University Bundang Hospital. Through this analysis, the study seeks to identify the long-term efficacy of FMT as a treatment for ulcerative colitis, evaluate the safety of the procedure, and establish a foundation for personalized FMT based on gut microbiota analysis.

NCT Number	NCT07154784
Lead Sponsor	Seoul National University Hospital Collaborators: Seoul National University Bundang Hospital, Inha University Hospital, Seoul National University Boramae Hospital
Conditions	Ulcerative Colitis, Fecal Microbiota Transplantation
Enrollment	30 participants
Start Date	2023-07-19
Primary Completion	2023-07-19 (estimated)
Study Completion	2027-06-30 (estimated)
Updated on ClinicalTrials.gov	2025-09-12